KENYAN ETHICS BOARD APPROVES COUNTRY'S FIRST CLINICAL TRIAL OF HERBAL PRODUCT USED TO TREAT HIV/AIDS

The Kenyatta National Hospital Ethics and Research Board recently approved the first human clinical trial in Kenya of an herbal product to treat HIV/AIDS, Kenya's Nation reports. The board approved a proposal by researchers from Kenya Medical Research Institute, the University of Nairobi and Kenyatta University to conduct a clinical trial to determine the safety of the Brazil-based herbal product Canova Immunomodulator, which contains three herbs -- Aconitum napellus, Bryonia alba and Thuya alba occentalis -- the metal Asenicum album and the venom of the poisonous snake Lachesis muta. MediLexicon (http://www.pharma-lexicon.com/medicalnews.php?newsid=51627)